Видео ютуба по тегу Fulvestrant

Fulvestrant in Breast Cancer
Fulvestrant in Breast Cancer
Role of Fulvestrant Monotherapy in HR+ mBC
Role of Fulvestrant Monotherapy in HR+ mBC
Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer
Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer
ALTERNATE: fulvestrant and/or anastrozole in ER+ HER2- postmenopausal breast cancer
ALTERNATE: fulvestrant and/or anastrozole in ER+ HER2- postmenopausal breast cancer
Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer
Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer
The significance of fulvestrant for hormone receptor-positive advanced breast cancer
The significance of fulvestrant for hormone receptor-positive advanced breast cancer
The Estrogen-Receptor Antagonist Fulvestrant in Breast Cancer
The Estrogen-Receptor Antagonist Fulvestrant in Breast Cancer
MONALEESA-3: Ribociclib Plus Fulvestrant in HR+ mBC
MONALEESA-3: Ribociclib Plus Fulvestrant in HR+ mBC
ESMO 2020 Highlights on alpelisib plus fulvestrant for HR+/HER2– ABC: The SOLAR-1 study
ESMO 2020 Highlights on alpelisib plus fulvestrant for HR+/HER2– ABC: The SOLAR-1 study
Fulvestrant in the Era of CDK4/6 Inhibitors for HR+ mBC
Fulvestrant in the Era of CDK4/6 Inhibitors for HR+ mBC
postMONARCH: abemaciclib with fulvestrant in pretreated HR+/HER2- breast cancer
postMONARCH: abemaciclib with fulvestrant in pretreated HR+/HER2- breast cancer
The Role of Fulvestrant in HR+ Breast Cancer
The Role of Fulvestrant in HR+ Breast Cancer
ASCO: Alpelisib Plus Fulvestrant for PIK3CA-Mutated Breast Cancer After Failure of CDK4/6 Inhibitors
ASCO: Alpelisib Plus Fulvestrant for PIK3CA-Mutated Breast Cancer After Failure of CDK4/6 Inhibitors
Introduction and Exploration of Fulvestrant in Metastatic Breast Cancer
Introduction and Exploration of Fulvestrant in Metastatic Breast Cancer
Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer
Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer
Is There Still a Role for Fulvestrant Hormone Monotherapy?
Is There Still a Role for Fulvestrant Hormone Monotherapy?
Second-line fulvestrant in pretreated metastatic invasive lobular carcinoma
Second-line fulvestrant in pretreated metastatic invasive lobular carcinoma
SERENA-2: camizestrant vs fulvestrant in post-menopausal women with advanced ER+/HER- breast cancer
SERENA-2: camizestrant vs fulvestrant in post-menopausal women with advanced ER+/HER- breast cancer
Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial
Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial